Physician profile
Monica Duran
NPI 1306358197
$971.20
in general payments reported to CMS, 2019-2025
9 companies · $33.20 in 2025
The $33.20 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.95 · 2022: $55.58 · 2023: $20.60 · 2024: $769 · 2025: $33.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $754 · Food and Beverage: $69.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $753.63 |
| Food and Beverage | $69.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $753.63 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Smith+Nephew, INC. | $42.54 | 2021-2025 | Collagenase Santyl |
| Kci USA, INC. | $42.53 | 2021 | |
| Ermi LLC | $38.85 | 2022 | |
| Depuy Synthes Sales INC. | $25.33 | 2021 | |
| Kyowa Kirin, INC. | $20.60 | 2023 | Crysvita |
| Abbvie INC. | $16.73 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.75 | 2025 | |
| Convatec INC. | $15.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Duran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.